Hepatitis C Study Demonstrates Potential for Therapeutic Vaccine | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

All About an HCV-Related Condition: Lichen Planus

Back to News Homepage
Next

Vulnerable Amino Acid May be Hepatitis C's Downfall

Hepatitis C Study Demonstrates Potential for Therapeutic Vaccine

The Editors at Hepatitis Central
November 23, 2009

Print this page

A recent study revealed that a therapeutic vaccine combined with a topical immune-enhancing agent initiated an immune response against the Hepatitis C virus.

Hep C Therapeutic Vaccine Shows Hints of Efficacy

November 18, 2009

A hepatitis C virus (HCV) therapeutic vaccine–designed to boost immune control of the virus in people already infected with HCV–has demonstrated that such an approach might work, according to a study presented at the American Association for the Study of Liver Disease (AASLD) Conference in Boston, and reported by aidsmap.

Because HCV mutates so easily, some experts have claimed that it might be impossible to develop a successful preventive vaccine for it. Others, however, have hoped that it might be possible to trigger the body to better control or ward off HCV infection.

Continue reading the entire article:
http://www.aidsmeds.com/articles/hiv_hcv_vaccine_1667_17601.shtml

No Comments - be the first!
Share
Share
Previous

All About an HCV-Related Condition: Lichen Planus

Back to News Homepage
Next

Vulnerable Amino Acid May be Hepatitis C's Downfall

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.